Representative Angie Craig Applauds Inclusion of Her Health Care Priorities in the Inflation Reduction Act
The Inflation Reduction Act reflects several of Craig’s legislative efforts to lower health care costs, including her Affordable Insulin Now Act – legislation that would cap the out-of-pocket cost of insulin at $35 per month
WASHINGTON, DC – Today, U.S. Representative Angie Craig applauded her Senate colleagues for efforts toward legislation that would take decisive action to ensure universal access to high-quality, affordable health care across our country. The Senate's current reconciliation framework reflects many of the health care priorities that Representative Craig has long advocated for, including capping the out-of-pocket cost of insulin at $35 per month, allowing Medicare to negotiate prescription drug prices and extension of the ACA tax credits.
"The Inflation Reduction Act would take historic steps to cap the out-of-pocket cost of insulin at $35 per month, empower Medicare to negotiate directly for the price of prescription drugs and implement long-term solutions to improve the quality of care in this country – all priorities I have fought tirelessly for since being elected to Congress," said Representative Craig. "I look forward to working with my colleagues to get these life-saving reforms across the finish line."
In Congress, Craig has helped lead the effort to address the high cost of prescription drugs in the United States by fighting to preserve Medicare price negotiations in previous reconciliation negotiations. While consistently advocating for the extension of the Affordable Care Act's premium tax credits, she has fought to save millions of Americans thousands of dollars annually on their health insurance premiums by urging the administration to close the ‘family glitch' and introducing legislation to lower premium costs on the individual marketplace by an estimated eight percent. Additionally, earlier this year, the House passed Representative Craig's Affordable Insulin Now Act, legislation that would cap the co-pay on insulin at $35 per month.
###